Evidence map›Paper›PMID 31348730›Full record

ArticlemAbs2019

Specific and high-resolution identification of monoclonal antibody fragments detected by capillary electrophoresis-sodium dodecyl sulfate using reversed-phase HPLC with top-down mass spectrometry analysis.

Wei-Han Wang, Jasmina Cheung-Lau, Yan Chen, Michael Lewis, Qing Mike Tang

Open access · goldAbstract read
In one paragraph

Article in mAbs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Advancements in the co-formulation of biologic therapeutics.Journal of controlled release : official journal of the Controlled Release Society · 2020
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wei-Han WangBio Therapeutics Development, Janssen Research & Development, LLC , Malvern , PA , USA.ORCID 0000-0001-6109-1645
Jasmina Cheung-LauBio Therapeutics Development, Janssen Research & Development, LLC , Malvern , PA , USA.ORCID 0000-0003-1766-9088
Yan ChenBio Therapeutics Development, Janssen Research & Development, LLC , Malvern , PA , USA.
Michael LewisBio Therapeutics Development, Janssen Research & Development, LLC , Malvern , PA , USA.
Qing Mike TangBio Therapeutics Development, Janssen Research & Development, LLC , Malvern , PA , USA.
Janssen (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, capillary electrophoresis-sodium dodecyl sulfate (cSDS) has been widely used for high resolution separation and quantification of the fragments and aggregates of monoclonal antibodies (mAbs) to ensure the quality of mAb therapeutics. However, identification of the low-molecular-weight (LMW) and high-molecular-weight (HMW) species detected in cSDS electropherograms has been based primarily on the approximate MWs calculated from standard curves using known MW standards and correlations with fragments and aggregates identified by other methods. It is not easy to collect sufficient amounts of H/LMW species from cSDS for analysis by orthogonal methods and the direct coupling of cSDS with mass spectrometry (MS) is very difficult due to interference from SDS. In this study, we describe the precise identification of H/LMW species detected by cSDS using reversed-phase high performance liquid chromatography (RP-HPLC) coupled with top-down tandem MS analysis. The H/LMW species were first identified by on-line RP-HPLC MS analysis and the RP-HPLC fractions were then analyzed by cSDS to connect the identified H/LMW species with the peaks in the cSDS electropherogram. With this method, 58 unique H/LMW species were identified from an immunoglobulin G1 (IgG1) mAb. The identified fragments ranged from 10 kDa single chain fragments to 130 kDa triple chain fragments, including some with post-translational modifications. This is the first study to clearly identify the antibody fragments, including the exact clipping sites, observed in cSDS electropherograms. The methodology and results presented here should be applicable to most other IgG1 mAbs.

Indexed as

AnimalsAntibodies, MonoclonalBiological ProductsChromatography, High Pressure LiquidChromatography, Reverse-PhaseElectrophoresis, CapillaryHumansImmunoglobulin FragmentsImmunoglobulin GImmunotherapyMass SpectrometryMolecular WeightProtein Aggregation, PathologicalProtein Processing, Post-TranslationalSodium Dodecyl SulfateAntibodies, MonoclonalBiological ProductsImmunoglobulin FragmentsImmunoglobulin GSodium Dodecyl SulfateaggregatesAntibodyclippingcSDSfragmentshigher energy collisional dissociation (HCD)high/low-molecular weight (H/LMW) speciespost-translational modification (PTM)size heterogeneitytop-down MS/MS

Identifiers

PMID31348730
PMCPMC6748579
OpenAlexW2966513039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.